Is There a Standard for Adjuvant Treatment of Dukes B and C Rectal Carcinoma?

Publisher： Karger

E-ISSN： 2296-5262|21|6|518-520

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.21, Iss.6, 1999-01, pp. : 518-520

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

p53 Gene Mutation, Microsatellite Instability and Adjuvant Chemotherapy: Impact on Survival of 388 Patients with Dukes’ C Colon Carcinoma

By  

Oncology, Vol. 58, Iss. 1, 2000-01 ,pp. : 52-59

Karger

Access to resources Recommend Favorite

Adjuvant Therapy after Curative Treatment for Hepatocellular Carcinoma

By  

Oncology, Vol. 81, Iss. 1, 2011-12 ,pp. : 50-55

Karger

Access to resources Recommend Favorite

Standard versus Hydrophilic Catheterization in the Adjuvant Treatment of Patients with Superficial Bladder Cancer

By  

Urologia Internationalis, Vol. 73, Iss. 1, 2008-06 ,pp. : 19-22

Karger

Access to resources Recommend Favorite

Chemoradiotherapy Alone as the Standard Treatment of Epidermoid Esophageal Carcinoma

By  

Oncology, Vol. 81, Iss. 3-4, 2011-11 ,pp. : 214-219

Karger

Access to resources Recommend Favorite

Adjuvant Treatment of Pancreatic Carcinoma in a Clinically Adapted Mouse Resection Model

By  

Pancreatology, Vol. 6, Iss. 3, 2006-07 ,pp. : 240-247

Karger

Access to resources Recommend Favorite